Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy

Autor: Mario Cortes-Pérez, Gloria García-Villalobos, Arturo Reding, Geovana Martin-Alemañy, Clara Rocío Hernández-Arciniega, Héctor Hinojosa-Heredia, Monserrat Pérez-Navarro, Guillermo Cantú-Quintanilla, Adrian Rodríguez-Matías, Ricardo Correa-Rotter, Ana Yetzin Camacho-Aguirre, Ernesto Chávez-López, Gregorio T. Obrador, Angel Valdez-Ortiz, Francisco Navarro-Reynoso, Irma Gómez-Guerrero, Rafael Valdez-Ortiz, Ma. Guadalupe Olvera-Soto
Rok vydání: 2018
Předmět:
Zdroj: Kidney International Reports
ISSN: 2468-0249
DOI: 10.1016/j.ekir.2018.06.004
Popis: Introduction Despite a systematic increase in the coverage of patients with end-stage renal disease (ESRD) who have received dialytic therapies and transplantation over the past 2 decades, the Mexican health system currently still does not have a program to provide full coverage of ESRD. Our aim was to analyze mortality in patients with ESRD without health insurance. Methods This was a prospective cohort study of 850 patients with advanced chronic kidney disease (CKD). Risk factors associated with death were calculated using a Cox's proportional hazards model. We used the statistical package SPSS version 22.0 for data analysis. Results The mean age of patients was 44.8 ± 17.2 years old. At the time of hospital admission, 87.6% of the population did not have a social security program to cover the cost of renal replacement treatment, and 91.3% of families had an income below US$300 per month. During the 3 years of the study, 28.8% of the cohort patients were enrolled in 1 of Mexico's social security programs. The 3-year mortality rate was of 56.7% among patients without access to health insurance, in contrast to 38.2% of patients who had access to a social security program that provided access to renal replacement therapy (P < 0.001). Risk factor analysis revealed that not having health insurance increased mortality (risk ratio: 2.64, 95% confidence intervals: 1.84−3.79; P = 0.001). Conclusion Mexico needs a coordinated National Kidney Health and Treatment Program. A program of this nature should provide the basis for an appropriate educational and intervention strategy for early detection, prevention, and treatment of patients with advanced chronic kidney disease.
Databáze: OpenAIRE